drugset / Trial / NCT05052879

Efficacy and Safety of Toronto Association in the Treatment of Erectile Dysfunction and Premature Ejaculation

NCT05052879

Phase 3 Not yet recruiting 232 enrolled EMS
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Toronto association in the treatment of both sexual dysfunction: erectile dysfunction and premature ejaculation.

Timeline

Start
2024-07
Primary completion
2026-05
Completion
2026-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tadalafil Small molecule 20 mg Oral
Subject Toronto association Unknown 20 mg Oral
Subject Toronto association Unknown 30 mg Oral
Subject Toronto association Unknown 60 mg Oral